Long-term gantenerumab Alzheimer's trial halted due to 'no regulatory path'
Washington University School of Medicine led a study evaluating long-term gantenerumab treatment in individuals with ...
Anti-Amyloid Drug Shows Promise In Preventing Alzheimer's
The drug, gantenerumab, was abandoned by its developers, but subsequent anti-amyloid drugs lecanemab ( Leqembi) and donanemab ...
ConsumerAffairs4h
New study identifies a drug that could prevent Alzheimer's symptoms
A new study conducted by researchers from the Washington University School of Medicine identified an experimental drug that ...
Becker's Hospital Review6h
Anti-amyloid therapy shows promise in delaying Alzheimer’s in at-risk patients
A study examining the long-term effects of anti-amyloid therapy gantenerumab suggests that full amyloid plaque removal may help reduce Alzheimer’s symptoms in individuals at risk for dominantly ...
Knowridge Science Report13h
New drug could delay Alzheimer’s symptoms, study shows
A new international study has offered hope that Alzheimer’s disease may one day be preventable—at least in people genetically ...
Swiss meditech Alcon inks eyecare deal with US's Lensar
Swiss eyecare firm Alcon said on Monday it has agreed to a deal worth a potential $430 million with US counterpart Lensar, ...